Search
Displaying 231–240 of 651 for “retinal diseases”
-
Curing Blindness, Part 1: Corey’s Story
Beacon StoriesHow gene therapy restored some of a boy’s sight.
-
Seeing Beyond Vision Loss: A Focus on Mental Health Resources for Patients with Retinal Disease
- Nov 11, 2025
- 7:00 p.m. (EDT)
- Virtual
Well-BeingJoin us for an insightful webinar exploring mental health care from both professional and patient perspectives. This webinar is for optometrists, ophthalmologists, retina specialists, genetic counselors, low vision rehabilitation professionals, mental health providers, and medical students.
-
A Family United: Thomas’ Hero’s Journey with CRB1
Beacon StoriesWhen Becky’s son Thomas was diagnosed with a rare CRB1-associated disease, their family’s world changed. But today, Becky and Thomas are embracing advocacy, community, and research as they work to raise awareness and fuel progress toward treatments and cures.
-
Advocacy Research News
In this in-depth interview hosted by InVivo, Jason Menzo, CEO of the Foundation Fighting Blindness, outlines the organization’s strategy for addressing significant changes and opportunities in the inherited retinal diseases (IRDs).
-
Research News
The company has also launched a natural history study of patients to inform the planned clinical trial.
-
Belite Bio Doses First Patient in Phase 3 Clinical Trial for Advanced Dry AMD (GA) Therapy
Research NewsThe company’s emerging, oral treatment is designed to slow vision loss
-
New Bipartisan Legislation Introduced to Boost Clinical Research for Treatments and Cures
Research NewsThe bill would provide loans to therapy developers ready to launch clinical trials for a broad range of conditions including eye diseases.
-
Lulie's Next Chapter for Light & Vision
Our vision is to recruit and retain a high performing and well-structured community-based grassroots Chapter leadership and membership. This focus will center around education, resources, and revenue throughout the community.
-
ProQR Completes Enrollment in Phase 2/3 Clinical Trial of RNA Therapy for LCA10
Research NewsCompany also announced progress in enrollment for Phase 1 / 2 clinical trials for emerging USH2A and RHO RNA therapies.
-
Lulie Gund: Beloved Philanthropist, Role Model and Confidant
Beacon StoriesLlura Gund, often referred to as Lulie, was known for her infectious kind smile and love of life.
